AbbVie to acquire Allergan in “transformative move”

Abbvie to acquire Allergan after entering into a definitive transaction agreement under which AbbVie will acquire the company in a cash and stock transaction...

Novartis acquires IFM Tre

Novartis will add to its broad portfolio of immunomodulatory medicines with the planned acquisition of IFM Tre, a subsidiary of IFM Therapeutics LLC focused...

GHO Capital acquires Sterling Pharma Solutions

European specialist investor in healthcare, GHO Capital, has acquired a majority stake in Sterling Pharma Solutions, a specialist in complex and difficult to manufacture...

Healthtech M&A and IPO Activity

The latest Healthtech M&A and IPO Activity Market Report from Hampleton Partners has revealed a final count of almost 100 deals in the healthtech...

DoseCare acquires Biodose

DoseCare announces its acquisition of Biodose, the UK’s only monitored dosage system (MDS) that accommodates liquid and solid medication. Biodose, a medication management solution,...

UK pharma pressing ahead with M&As in 2019

The UK pharmaceutical industry is pressing ahead with M&A activity and is geared to weather any disruption due to Brexit, according to the results...

Sanofi and Denali join forces on inflammatory disease drugs

Sanofi plans to collaborate with Denali Therapeutics Inc. on the development of multiple molecules with the potential to be neurological and systemic inflammatory disease...

AstraZeneca divests rights for Nexium and Vimovo to Grünenthal

AstraZeneca has agreed to divest the prescription medicine rights for Nexium in Europe, as well as the global rights (excluding the US and Japan)...

Mundipharma acquires biosimilars development company

The Mundipharma global network of independent associated companies has added development capabilities to its biosimilars platform with the purchase of biosimilars development company, Cinfa...

BioIVT acquires CTLS a UK blood donor facility

BioIVT acquires Clinical Trials Laboratory Services (CTLS), a donor centre and laboratory based in London, UK. BioIVT, is a provider of research models and...

Latest articles

Image of a scientist at a lab to show Life sciences industry releases COVID-19 testing and diagnostics FAQs

Life sciences industry releases COVID-19 testing and diagnostics FAQs

The life sciences industry released a joint statement on COVID-19 testing and diagnostics along with useful COVID-19 testing and diagnostics FAQs. The FAQs have been...
Image of a scientist testing to show Life sciences COVID-19 testing and diagnostics statement

Life sciences’ COVID-19 testing and diagnostics statement

The life sciences industry has released a joint statement on COVID-19 testing and diagnostics as the Government confirms that testing capacity will increase. The statement...
Image of a target with an arrow in the middle to show Rapid COVID-19 diagnostic test to be deployed in hospitals

Rapid COVID-19 diagnostic test to be deployed in hospitals

A new rapid COVID-19 diagnostic test developed by a University of Cambridge spinout company and capable of diagnosing the infection in under 90 minutes,...

Popular articles

Image of a target with an arrow in the middle to show Rapid COVID-19 diagnostic test to be deployed in hospitals

Rapid COVID-19 diagnostic test to be deployed in hospitals

A new rapid COVID-19 diagnostic test developed by a University of Cambridge spinout company and capable of diagnosing the infection in under 90 minutes,...
Image of a form with ticks to show MHRA guidance on coronavirus (COVID-19)

UPDATED: MHRA guidance on coronavirus (COVID-19)

The MHRA is producing guidance on coronavirus (COVID-19) for industry. The Medicines and Healthcare products Regulatory Agency (MHRA) is working closely with Department of Health...
Image of lab equipment to show Synairgen to start trial of SNG001 in COVID-19

Synairgen to start trial of SNG001 in COVID-19

Respiratory drug discovery and development company Synairgen has received expedited approvals from the Medicines and Healthcare products Regulatory Agency (MHRA) and Health Research Authority...
Image of a hospital corridor to show Interim analysis data for Siltuximab-Treated COVID-19 Patients from the SISCO Study

Interim analysis data for Siltuximab-Treated COVID-19 Patients study

An update on the Siltuximab clinical study brings interim analysis data for Siltuximab-Treated COVID-19. EUSA Pharma has announced the initial preliminary findings from the Papa...
Seqirus starts on-time delivery of NHS flu vaccines

Seqirus starts on-time delivery of NHS flu vaccines

Seqirus has started on-time shipping of its NHS flu vaccines portfolio, FLUAD® (aTIV) and FLUCELVAX® TETRA▼(QIVc), to healthcare professionals across the UK. Delivering Seqirus’ flu...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription